Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease

Molecular Medicine

Volumn 20, Issue 1, 2014, Pages 290-301

  Mittal, Amit K ^a   Chaturvedi, Nagendra K ^a   Rai, Karan J ^a   Gilling Cutucache, Christine E ^a   Nordgren, Tara M ^a   Moragues, Margaret ^b   Lu, Runqing ^a   Opavsky, Rene ^a   Bociek, Greg R ^b   Weisenburger, Dennis D ^a   Iqbal, Javeed ^a   Joshi, Shantaram S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR; TNFSF13B PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER PROGNOSIS; CCL3 GENE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKEMIA CELL; LYMPH NODE; LYMPHADENOPATHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ANIMAL; BLOOD; C57BL MOUSE; DISEASE COURSE; GENETICS; METABOLISM; MIDDLE AGED; SPLEEN; TRANSGENIC MOUSE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; B-CELL ACTIVATING FACTOR; BONE MARROW; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; NF-KAPPA B; RECEPTORS, ANTIGEN, B-CELL; SPLEEN; TUMOR MICROENVIRONMENT;

EID: 84904326052     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00303     Document Type: Article

References (45)

1. Chiorazzi N. (2007) Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract. Res. Clin. Haematol. 20:399-413.
2. Messmer BT, et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 115:755-64.
3. Defoiche J, et al. (2008) Reduction of B cell turnover in chronic lymphocytic leukaemia. Br. J. Haematol. 143:240-7.
4. Chiorazzi N, Rai KR, Ferrarini M. (2005) Chronic lymphocytic leukemia. N. Engl. J. Med. 352:804-15.
5. Burger JA, Kipps TJ. (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk. Lymphoma. 43:461-6.
6. Carbone A, Gloghini A, Cabras A, Elia G. (2009) The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br. J. Haematol. 145:468-80.
7. Ayala F, Dewar R, Kieran M, Kalluri R. (2009) Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia. 23:2233-41.
8. Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. (2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 114:3367-75.
9. Burger JA, et al. (2009) High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood. 113:3050-8.
10. Ding W, et al. (2009) Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression. Br. J. Haematol. 147:471-83.
11. Pedersen IM, et al. (2002) Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood. 100:1795-801.
12. Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ. (2002) Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia. Blood. 99:1030-7.
13. Lapalombella R, et al. (2009) The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia. Br. J. Haematol. 144:848-55.
14. Mittal AK, et al. (2008) Molecular basis of proliferation/survival and migration of CLL in peripheral blood, bone marrow and lymph nodes. Blood. 112(11). ASH Annual Meeting abstract no. 546.
15. Herishanu Y, et al. (2008) The role of the microenvironment for CLL proliferation and survival: gene expression profiling of leukemic cells derived from blood, bone marrow and lymph nodes reveals the B-cell receptor and NF nB as dominant signaling pathways. Blood. 112(11). ASH Annual Meeting abstract no. 356.
16. Mittal AK, et al. (2009) Clinical heterogeneity of CLL: role for immune dysregulation mediated by the lymph node microenvironment. Blood. 114(22). ASH Annual Meeting abstract no. 1243.
17. Herishanu Y, et al. (2009) Comparative gene expression profiling of leukemia cells in peripheral blood and tissue compartments reveals a prominent role of the microenvironment for CLL cell proliferation. Blood. 114(22). ASH Annual Meeting abstract no. 355.
18. Herishanu Y, et al. (2011) The lymph node micro-environment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 117:563-74.
19. Vandewoestyne ML, et al. (2011) Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/ small lymphocytic lymphoma and proliferating B cells within lymph node pseudofollicles. Leukemia. 25:883-8.
20. Joshi AD, et al. (2007) ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clin. Cancer Res. 13:5295-304.
21. Joshi AD, et al. (2007) Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion. Cancer Genet. Cytogenet. 172:120-6.
22. Mittal AK, et al. (2007) Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Int. J. Mol. Med. 20:461-9.
23. Tusher VG, Tibshirani R, Chu G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-21.
24. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-50.
25. Hegde GV, et al. (2008) Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol. Cancer. Res. 6:1928-36.
26. Falt S, et al. (2005) Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. Blood. 106:681-9.
27. Hoellein A, et al. (2010) Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status. J. Cancer Res. Clin. Oncol. 136:403-10.
28. Dempsey NC, Ireland HE, Smith CM, Hoyle CF, Williams JH. (2010) Heat shock protein translocation induced by membrane fluidization increases tumor-cell sensitivity to chemotherapeutic drugs. Cancer Lett. 296:257-67.
29. Pleyer L, Egle A, Hartmann TN, Greil R. (2009) Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nat. Rev. Clin. Oncol. 6:405-18.
30. Quiroga MP, et al. (2009) B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood. 114:1029-37.
31. Bojarska-Junak A, et al. (2009) BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Leuk. Res. 33:1319-27.
32. Redondo-Munoz J, Jose Terol M, Garcia-Marco JA, Garcia-Pardo A. (2008) Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood. 111:383-6.
33. Burger M, et al. (2005) Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood. 106:1824-30.
34. Barretina J, et al. (2003) CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease. Ann. Hematol. 82:500-5.
35. Sivina M, et al. (2011) CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 117:1662-9.
36. Sasaki H, et al. (2005) Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood. 105:1204-13.
37. Calissano C, et al. (2011) Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells. Mol. Med. 17:1374-82.
38. Gilling CE, et al. (2012) Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1. Br. J. Haematol. 158:216-31.
39. Yu J, et al. (2013) Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 190:3783-97.
40. Efanov A, et al. (2010) CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. Leukemia. 24:970-5.
41. Oppezzo P, Dighiero G. (2013) Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia. Blood Cancer J. 3:e149.
42. Ramsay AD, Rodriguez-Justo M. (2013) Chronic lymphocytic leukaemia: the role of the microenvironment pathogenesis and therapy. Br. J. Haematol. 162:15-24.
43. Cols M, et al. (2012) Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J. Immunol. 188:6071-83.
44. Cosimo E, et al. (2013) Inhibition of NF-kappaBmediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clin. Cancer Res. 19:2393-405.
45. Smit LA, et al. (2007) Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood. 109:1660-8.